Inovio Pharmaceuticals (INO) - News Mentions

Sign up to add (INO) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 0 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 2 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
BridgeBio Pharma
BridgeBio Pharma
BBIO		 0 100%
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Update
December 4
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
December 2
INOVIO Reports Inducement Grant under Inducement Plan
December 1
INOVIO Reports Inducement Grant Under Inducement Plan
November 29
HC Wainwright Issues Optimistic Forecast for INO Earnings
November 20
Inovio Pharmaceuticals (NASDAQ:INO) Price Target Cut to $6.00 by Analysts at Royal Bank of Canada
November 19
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Rating of “Moderate Buy” by Brokerages
November 16
Desjardins Issues Negative Outlook for TSE:INO Earnings
November 16
Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023)
November 15
Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ...
November 14
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript
November 14
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 14
Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript
November 14
Inovio Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation
November 14
Inovio Pharmaceuticals : Reports Third Quarter 2024 Financial Results and Recent Business Highlights Form 8 K
November 14
Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial
November 13

Month over Month

Est. daily news mentions.

Nov 2024 0
Oct 2024 0
Sep 2024 0
Aug 2024 0
Jul 2024 0

How often is Inovio Pharmaceuticals mentioned in the news?

Inovio Pharmaceuticals was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Inovio Pharmaceuticals performing compared to its industry peers?

Inovio Pharmaceuticals underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Inovio Pharmaceuticals in the last month?

There has been no significant change in the number of news mentions for Inovio Pharmaceuticals' compared to the last month.

Why is it important to track news mentions for Inovio Pharmaceuticals?

By monitoring mentions in the news for Inovio Pharmaceuticals, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Inovio Pharmaceuticals, ultimately improving their investment strategies.

Sign up and get more insights on Inovio Pharmaceuticals.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact